GSK, GB00BN7SWP63

GSK stock slips to EUR 22.86, down 1.00% premarket

Published on 11/17/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GSK operates across specialty medicines, vaccines and general medicines. On Xetra, the stock closed at EUR 23.09 on Monday, November 16, 2026.

What Shapes GSK Stock Now

  • GSK operates across specialty medicines, vaccines and general medicines.
  • Patent expiries in the HIV franchise remain a long-term risk for the drugmaker.
  • Pipeline investment is central to replacing products that face loss of exclusivity.
GSK, GB00BN7SWP63, Illustration mit AI erstellt.

GSK stock traded at EUR 22.86 on Lang & Schwarz at 07:48 CET on Tuesday, November 17, 2026, 1.00 percent below the Xetra close of EUR 23.09 on Monday, November 16.

GSK operates across specialty medicines, vaccines and general medicines, according to AJ Bell. Investors continue to weigh pipeline growth against patent expiries in the HIV franchise.

Broader UK equities can be followed in the FTSE 100.

More news and analyses on GSK stock.

Disclaimer...
en | GB00BN7SWP63 | GSK | boerse | 70525101 | bgmi